首页> 外国专利> Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses

Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses

机译:3-羟基-4-吡喃酮镓配合物可治疗细胞内原核生物和DNA病毒的感染

摘要

Methods are provided for treating or preventing infections by obligate intracellular prokaryotes, including mycoplasma, rickettsia and chlamydia, and DNA viruses, including herpes viruses, papillomaviruses, adenoviruses and hepatitis B virus. The methods involve the administration of 3:1 complexes of 3-hydroxy-4-pyrones with gallium, e.g., gallium maltolate. Therapies incorporating gallium maltolate in combination with agents used against obligate intracellular prokaryote and DNA virus pathogens are also provided, as are multi-combination therapies designed to treat co-infection by an obligate intracellular prokaryote or DNA virus in an immunocompromised individual. These multi-combination therapies rely on the ability of gallium maltolate to complement antiviral medication regimes against both HIV and other pathogens such as herpesvirus infections, including Kaposi sarcoma, CMV retinitis and blindness, and lymphomas, in patients immunocompromised by HIV infection.
机译:提供了用于治疗或预防专性细胞内原核生物(包括支原体,立克次氏体和衣原体)以及DNA病毒(包括疱疹病毒,乳头瘤病毒,腺病毒和乙型肝炎病毒)感染的方法。所述方法包括将3-羟基-4-吡喃酮与镓例如麦芽酸酯镓的3∶1配合物给药。还提供了将麦芽糖镓与用于抵抗专性细胞内原核生物和DNA病毒病原体的试剂组合的疗法,以及设计用于治疗免疫受损的个体中专性细胞内原核生物或DNA病毒的共同感染的多组合疗法。这些多组合疗法依赖于麦芽酚镓补充抗HIV和其他病原体(如疱疹病毒感染,包括卡波西肉瘤,CMV视网膜炎和失明以及淋巴瘤)的抗病毒药物治疗方案的能力,这些患者被HIV感染免疫受损。

著录项

  • 公开/公告号US2006222628A1

    专利类型

  • 公开/公告日2006-10-05

    原文格式PDF

  • 申请/专利权人 LAWRENCE R. BERNSTEIN;

    申请/专利号US20050267088

  • 发明设计人 LAWRENCE R. BERNSTEIN;

    申请日2005-11-04

  • 分类号A61K38/20;A61K38/21;A61K31/555;A61K31/522;A61K31/202;

  • 国家 US

  • 入库时间 2022-08-21 21:45:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号